Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(10%)
Results Posted
67%(6 trials)

Phase Distribution

Ph phase_1
3
30%
Ph phase_2
1
10%
Ph phase_3
5
50%

Phase Distribution

3

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
5(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(9)

Detailed Status

Completed9
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (33.3%)
Phase 21 (11.1%)
Phase 35 (55.6%)

Trials by Status

recruiting110%
completed990%

Recent Activity

1 active trials
Showing 5 of 10
completed

Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections and Acute Osteomyelitis

NCT04714411
completedphase_3

Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia

NCT04779242
completedphase_1

Microbiome Effect of Omadacycline on Healthy Volunteers

NCT06030219
recruitingphase_3

A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

NCT06162286
completedphase_1

Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia

NCT04160260
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04714411

Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections and Acute Osteomyelitis

Completed
NCT04779242Phase 3

Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia

Completed
NCT06030219Phase 1

Microbiome Effect of Omadacycline on Healthy Volunteers

Completed
NCT06162286Phase 3

A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

Recruiting
NCT04160260Phase 1

Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia

Completed
NCT04144374Phase 1

Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Completed
NCT03757234Phase 2

IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis

Completed
NCT02378480Phase 3

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

Completed
NCT02531438Phase 3

Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)

Completed
NCT02877927Phase 3

Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10